Scandinavian Medical Solutions AS (SMSMED) — Capital Reinvestment Ratio
Latest as of September 2024:
0.85x
Scandinavian Medical Solutions AS (SMSMED) has a Capital Reinvestment Ratio of 0.85x as of September 2024, meaning it reinvests 1% of its operating cash flow (Dkr17.86 Million) in capital expenditures (Dkr15.13 Million). See SMSMED free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.85x
Capex / Operating Cash Flow
Operating Cash Flow
Dkr17.86 Million
DKK
Capital Expenditures
Dkr15.13 Million
DKK
Data as of
Sep 2024
Most recent filing
Scandinavian Medical Solutions AS Capital Reinvestment Ratio (2020–2024)
This chart tracks Scandinavian Medical Solutions AS's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Scandinavian Medical Solutions AS (2020–2024)
Year-by-year Capital Reinvestment Ratio for Scandinavian Medical Solutions AS from 2020 to 2024. For live market cap and broader valuation context, see SMSMED market cap overview.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 5.44x | Dkr3.39 Million | Dkr18.47 Million | ▲ +438250430.7% |
| 2021 | 0.00x | Dkr4.02 Million | Dkr5.00 | ▼ -100.0% |
| 2020 | 1.47x | Dkr9.38 Million | Dkr13.76 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow